Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 174 publications
Large Language Models and Adverse Event Detection Within Immunotherapy Clinical Trials.
Journal: JAMA network open
Published: September 03, 2026
Lyophilized platelet derived extracellular vesicles promote hemostasis and attenuate intracranial hemorrhage following traumatic brain injury.
Journal: Journal of translational medicine
Published: June 06, 2026
Strategic engineering B cell immunity for cancer immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 24, 2026
Impact of hepatitis C viremia on overall survival and hepatic decompensation among patients with unresectable HCC receiving immunotherapy.
Journal: Clinical and translational gastroenterology
Published: April 09, 2026
Functionally heterogeneous intratumoral CD4+CD8+ double-positive T cells can give rise to single-positive T cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 20, 2026
Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer.
Journal: Clinical colorectal cancer
Published: December 06, 2025
Phase I multi-center clinical and biomarker study of the dual-action androgen receptor inhibitor ONCT-534.
Journal: Investigational new drugs
Published: November 14, 2025
A Phase II Trial of Pembrolizumab plus Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Biliary Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 23, 2025
Engineered human iPSC-derived dendritic cells dressed with tumor MHC complexes as a cancer vaccine.
Journal: Cell stem cell
Published: October 21, 2025
Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastases.
Journal: Science advances
Published: October 08, 2025
Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction.
Journal: JHEP reports : innovation in hepatology
Published: August 03, 2025
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myeloma.
Journal: Haematologica
Published: April 07, 2025
Last Updated: 09/26/2026